Search research articles
Contact Us
Filters
Showing results (131-140 of 154) with videos related to
Page
of 16
Sort By:
Endocrinology
|
December 6, 1997
Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument
A Martínez, T H Elsasser, C Muro-Cacho, et al.
Synapse (New York, N.Y.)
|
January 1, 1988
(D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists
Z Merali, C A Merchant, J N Crawley, et al.
Life Sciences
|
January 1, 1997
PACAP hybrid: a new PACAP receptor antagonist
J R Pisegna, J Leyton, T Coelho, et al.
Cancer Research
|
August 1, 1996
Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist
H Zia, T Hida, S Jakowlew, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines
M Lee, M Draoui, F Zia, et al.
Life Sciences
|
January 1, 1997
(Stearyl, Norleucine17)VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells
T W Moody, J Leyton, T Coelho, et al.
Peptides
|
November 1, 1988
Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth
G Bepler, U Zeymer, S Mahmoud, et al.
Cancer Research
|
July 15, 1995
Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer
C S John, B J Vilner, M E Gulden, et al.
Experimental Lung Research
|
February 24, 2001
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis
Y Kang, M A Prentice, J M Mariano, et al.
Brain Research
|
September 23, 1985
Deafferentation causes a loss of presynaptic bombesin receptors and supersensitivity of substance P receptors in the dorsal horn of the cat spinal cord
V J Massari, C W Shults, C H Park, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 154) with videos related to
Sort By:
Page
of 16
Endocrinology
|
December 6, 1997
Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument
A Martínez, T H Elsasser, C Muro-Cacho, et al.
Synapse (New York, N.Y.)
|
January 1, 1988
(D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists
Z Merali, C A Merchant, J N Crawley, et al.
Life Sciences
|
January 1, 1997
PACAP hybrid: a new PACAP receptor antagonist
J R Pisegna, J Leyton, T Coelho, et al.
Cancer Research
|
August 1, 1996
Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist
H Zia, T Hida, S Jakowlew, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines
M Lee, M Draoui, F Zia, et al.
Life Sciences
|
January 1, 1997
(Stearyl, Norleucine17)VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells
T W Moody, J Leyton, T Coelho, et al.
Peptides
|
November 1, 1988
Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth
G Bepler, U Zeymer, S Mahmoud, et al.
Cancer Research
|
July 15, 1995
Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer
C S John, B J Vilner, M E Gulden, et al.
Experimental Lung Research
|
February 24, 2001
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis
Y Kang, M A Prentice, J M Mariano, et al.
Brain Research
|
September 23, 1985
Deafferentation causes a loss of presynaptic bombesin receptors and supersensitivity of substance P receptors in the dorsal horn of the cat spinal cord
V J Massari, C W Shults, C H Park, et al.
Page
of 16